Exicure, inc. announces adjournment of annual meeting of stockholders

Chicago--(business wire)--exicure, inc. (nasdaq: xcur), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting rna to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that the company's annual meeting of stockholders (the “annual meeting”) held in virtual format on friday, may 27, 2022 at 1:00 p.m. central time, was convened and adjourned until june 10, 2022 at 1:00 p.m. central time
XCUR Ratings Summary
XCUR Quant Ranking